OncoGenex Pharmaceuticals reports financial results for third quarter 2014
OncoGenex reported the net loss for the 2014 third quarter was $4.9 million versus a net loss of $10.1 million in the same 2013 period. Revenue for the 2014 third quarter was $4.8 million versus $9.9 million in the same 2013 period. October 30, 2014